2022 HOSPITALAR Brazil was grandly launched. Innolcon, as one of the few Chinese professional manufacturers, made a dazzling appearance and attracted the attention of the crowd.

       Affiliated with the International Hospital Federation, HOSPITALAR Brazil is the largest and most comprehensive medical industry exhibition in South America, which has been successfully held for 27 sessions so far. A total of 1,000 exhibitors from more than 70 countries and regions and nearly 90,000 professionals were invited to witness the latest products and cutting-edge technologies in the medical industry. 
 

       As the first ultrasonic scapel manufacturer in China to break through the 5mm technology barrier, Innolcon made its debut on HOSPITALAR. Doctors who experienced the SG, SS and RSG series on site gave high praise to Innolcon, saying that both in design and workmanship and in dissection and coagulation, Innolcon has reached the level of internationally renowned brands. Many distributors also actively contacted Innolcon after the exhibition, expressing great interest in starting cooperation.
       This exhibition further demonstrates Innolcon's determination to pursue greater development in the international market, and further proves Innolcon's profound technical heritage and excellent brand leadership.  

       Dedicated to the research and development of ultrasonic energy technology, Innolcon quickly opened up the domestic market after obtaining the first class III 5mm registration certificate in 2020. At the same time, great news have been reported frequently from the international market. In May 2021, Innolcon successfully obtained ANVISA certification in Brazil, which also marked Innolcon's official entry into the Brazilian market and the full opening of regional cooperation in Latin America. With excellent product quality and superior cooperation channels, Innolcon has become the mainstay of China-made brand in Latin America with multi-site advancement and deep penetration.   

       From 2021 to 2022, Innolcon's international market has gained continuous breakthroughs rapid growth in exports share. As the mainstream demand of minimally invasive surgery, the gun type scapel has been gradually recognized by international experts in the field of laparoscopy such as gastrointestinal surgery. among which the 45 series has won unanimous praise from bariatric experts; the scissor type scalpel is routinely used in thyroid and breast surgery, and also provides better surgical experience for hepatobiliary surgery and spinal tumor surgery. 

       This exhibition laid a solid foundation for Innolcon to further cultivate the Latin American market, and allowed more doctors and potential partners to directly experience Innolcon's excellent products and services, which injected confidence for subsequent in-depth cooperation. Innolcon is looking forward to establishing long-term cooperation with partners and doctors in all regions of the world in the future, so that we can meet more possibilities together. Innolcon will continue to "share medical progress" and actively promote the all-platform energy surgery strategy, relying on solid R&D technology, efficient service and professional partners to provide better surgical solutions for the global market.

       We look forward to meeting you in the future.